Tailoring egg proteins for high-performance functional food ingredients

Overview

This research program develops a scalable, food-grade platform that converts egg-derived feedstocks—whole egg, white, and yolk—into tailored, high-performance protein ingredients. By selectively fractionating and modifying egg proteins, the platform can generate multiple application-specific ingredients from a single feedstock, ranging from highly functional intact proteins to soluble peptide-rich fractions. Target applications include beverages, powders, bars, frozen desserts, and clinical or sports nutrition.

The core value proposition is tunability: instead of a one-size-fits-all ingredient, processors can adjust processing intensity and fraction composition to dial in specific functional properties such as solubility, viscosity, heat stability, foaming, and emulsification. This flexibility supports product developers seeking clean-label, egg-derived solutions for gluten-free baking, aerated foods, and high-protein nutrition formats.

Technical specifications

The platform combines four complementary processing technologies:

• Controlled ultrasound to modify protein structure, particle size, and rheology, improving foaming performance and stability when applied at low intensity.
• Enzymatic hydrolysis to generate peptide-rich fractions with tailored solubility and biofunctional potential.
• Membrane separation (ultrafiltration/diafiltration) to produce intact-protein and peptide streams with defined molecular weight profiles.
• Transglutaminase-mediated crosslinking to create structured protein networks for gluten-free bulking and texturizing systems, as well as stable aerated foods.

Key functional responses being optimized include particle size, zeta potential, solubility, viscosity, heat stability, foaming, emulsification, gel strength, overrun, bubble size, drainage, and foam half-life. The process is designed to be food-grade and scalable, with pilot-scale continuous flow-through ultrasound and membrane systems planned for later-stage validation.

Technology readiness level

The program is at an early development stage, with preliminary trials on egg white demonstrating that low-intensity ultrasound can improve foaming performance and stability, while excessive treatment reduces functionality. Recent studies also support the use of ultrasound, enzymatic modification, and transglutaminase crosslinking to improve egg protein functionality and gluten-free food structure.

The proposed validation plan spans 12 months: establishing baselines and design-of-experiments optimization (months 0–3), combining lead ultrasound conditions with controlled hydrolysis and membrane separation (months 3–6), optimizing crosslinking and aeration (months 6–9), and validating ingredients in beverage, gluten-free, and frozen/aerated model systems before transfer to pilot trials (months 9–12). Go/no-go criteria focus on functionality and reproducibility. Partner support is sought for pilot equipment, application testing, and regulatory or scale-up guidance.